je.st
news
Why Gilead Is A Better Buy Than AbbVie
2014-12-06 02:39:31| Biotech - Topix.net
The stock price appreciation of biotech juggernaut Gilead Sciences has stalled recently as the biotech giant consolidates recent gains and as some worries about competition in hepatitis C space increases. I have seen a lot of comments and commentary around how AbbVie could be a major player in the hepatitis C arena in the medium term.
Tags: than
buy
gilead
abbvie
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||